Therapy could also be aimed at any one of the many target cells for HIV infection in vivo, including immune cells such as CD4+ and CD8+ T cells, dendritic cells, monocytes, macrophages, hematopoietic stem cells (HSCs), brain cells, and other cells from the gastrointestinal tracts that could serve as host cells for HIV. This evidence concerns the gene CD4 and HIV infectious disease.